Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-4172
Abstract: Background: Ciltacabtagene autoleucel (cilta-cel) targets B-cell maturation antigen (BCMA) in multiple myeloma (MM). Rare, potentially life-threatening late-onset neurotoxicity syndromes associated with BCMA targeting encompass movement and neurocognitive treatment-emergent adverse events (MNTs). Underlying pathomechanisms of this…
read more here.
Keywords:
bcma;
cilta cel;
mnt onset;
car ... See more keywords